(Q91841847)

English

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 19 February 2019

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

based on heuristic

inferred from title

phase III clinical trial

1 reference

based on heuristic

inferred from title

author name string

Michael Gnant

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Georg Pfeiler

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Günther G Steger

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Daniel Egle

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Richard Greil

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Florian Fitzal

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Viktor Wette

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Marija Balic

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Ferdinand Haslbauer

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Elisabeth Melbinger-Zeinitzer

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Vesna Bjelic-Radisic

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Raimund Jakesz

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Christian Marth

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Paul Sevelda

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Brigitte Mlineritsch

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Ruth Exner

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Christian Fesl

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Sophie Frantal

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Christian F Singer

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Austrian Breast and Colorectal Cancer Study Group

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

publication date

19 February 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

339-351

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fracture incidence after 3 years of aromatase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of bisphosphonates in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral bisphosphonate compliance and persistence: a matter of choice?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine aspects of bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone metastasis: the importance of the neighbourhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update Summary.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The RANKL-RANK Story

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Correcting for non-compliance in randomized trials using rank preserving structural failure time models

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone health in cancer patients: ESMO Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased fracture rate in women with breast cancer: a review of the hidden risk

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of RANKL-Targeted Therapy in Immunity and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Roles of the RANKL–RANK axis in antitumour immunity — implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast-cancer adjuvant therapy with zoledronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of bone-targeted agents on cancer progression and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930862-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(18)30862-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30795951%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q91841847&oldid=1605492667"